Categories: Health and Public Health

They’re not just sharing needles, they’re sharing blood: How HIV cases soared in Fiji

They’re not just sharing needles, they’re sharing blood: How HIV cases soared in Fiji

Introduction: A rising crisis in a Pacific nation

Fiji, a small island nation in the South Pacific with a population under one million, has become a focal point of one of the world’s fastest-growing HIV epidemics. Over the past decade, the country has moved from a handful of cases to thousands, driven by a convergence of unsafe drug use, sexual transmission, and alarming new practices in blood-sharing. The human stories behind the statistics reveal a crisis that touches young people, communities, and the health system alike.

Understanding the drivers: drugs, blood-sharing, and stigma

At the heart of Fiji’s surge is a dangerous pattern known locally as “bluetoothing,” where people intravenously inject drugs and, in some cases, share blood as a way to extend a single hit. This practice, described by frontline workers as more than just needle-sharing, has helped spread HIV quickly among groups of young users. Experts warn that the behavior is compounded by methamphetamine use and other chemsex activities that facilitate unsafe sex and risky injection practices.

Public health officials point to a broader context: limited access to clean injecting equipment and a patchy network of needle-syringe programs. Pharmacies and police pressure have impeded the easy acquisition of syringes, pushing some drug users toward dangerous sharing practices. The Ministry of Health and Medical Services has acknowledged bluetoothing as a driver of transmission, alongside high rates of sexual transmission and, for some children, mother-to-child transmission.

Youth and vulnerability: a troubling age trend

One of the most shocking aspects of the epidemic is its age profile. While HIV was once concentrated among adults, the newest waves of infections increasingly involve teenagers and people in their early twenties. Advocates describe a cityscape where “more young people are using drugs,” and where the youngest known patient was a child who would be ten years old when first encountered by survivor advocates. The data show 2024 recording 1,583 new cases—much higher than recent averages—with a notable number of cases among those aged 15 or younger. This shift raises urgent questions about education, prevention, and access to care for youth at risk.

Response and capacity: policy, testing, and gaps

In January, Fiji declared an HIV outbreak, signaling a national recognition that more resources were needed. Health officials have sought to bolster surveillance and improve diagnosis and treatment, but reports from regional experts emphasize persistent bottlenecks: staffing shortages, supply chain hiccups for rapid tests and medicines, and slow, error-prone data collection that makes it hard to understand the epidemic’s true scale. The World Health Organization’s Global Alert and Response Network has urged a coordinated national response, stressing the importance of expanding testing, reducing stigma, and accelerating access to antiretroviral therapy.

What experts fear next: a potential avalanche

Analysts warn that Fiji’s outbreak is not simply a snapshot but a looming issue. Some experts describe the current period as the “beginning of the avalanche,” suggesting that the infections occurring now may only be detected in the coming years as people become tested and treated. Without substantial investment in harm-reduction programs, education, and community-based support, the trajectory could continue to rise, undermining public health gains and placing further strain on a health system already navigating resource constraints.

What is needed: education, access, and community support

Voices from Fiji’s NGO sector stress three pillars for turning the tide: comprehensive education that reaches young people with accurate information about HIV and transmission routes; expanded access to clean injecting equipment through needle-syringe programs; and robust, stigma-free testing and treatment services that can reach at-risk communities. The experience of organizations like Survivor Advocacy Network and Drug Free Fiji shows how targeted outreach can help reduce risk and connect people to care, but systemic support is essential to scale these efforts.

Conclusion: a national crisis requiring sustained action

Fiji’s HIV rise is a sobering reminder that epidemics are shaped by behavior, policy, and access to health services as much as by biology. As young people increasingly bear the burden, the country faces a critical test: can it build the infrastructure, funding, and community trust needed to reverse this trajectory and protect its most vulnerable citizens?